Study examines variation in intensity of fracture-associated prescription drug use
High public support for strict COVID measures but lower level of trust in government
16 February 2021Ablation beats drug therapy for women and men with A-fib
16 February 2021Study examines variation in intensity of fracture-associated prescription drug use
Findings from a new Geisel-led study, published in the Journal of General Internal Medicine, reveal that there is substantial variation across different regions of the country in the intensity of fracture-associated drug (FAD) use among long-term care facility residents, and that areas with greater use of these prescription drugs experience higher hip fracture rates.
